NSE · MKPL · Edible Oil
M.K.Proteins Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹268 Cr with net profit ₹8 Cr — a 3.13% net margin, versus 4.56% the period before.
Shareholding
As of 2026-06-30
- Promoter74.83%
- Public25.18%
70,737 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.49× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Solvent Extraction · ranked #1 of 30 by market cap · medians across 24 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Marico Limited | ₹1,13,796 Cr | 288.31 | 27.06 | 41.85% | 12.95% |
| Patanjali Foods Limited | ₹37,371 Cr | 71.26 | 2.85 | 15.37% | 4.52% |
| AWL Agri Business Limited | ₹24,635 Cr | 83.87 | 2.35 | 9.98% | 1.39% |
| Gokul Agro Resources Ltd. | ₹6,335 Cr | 53.27 | 2.23 | 25.96% | 1.53% |
| CIAN Agro Industries & Infrastructure Ltd. | ₹4,002 Cr | 17.97 | 1.89 | 10.34% | 10.05% |
| Avt Natural Products Ltd. | ₹1,072 Cr | 48.57 | 1.92 | 11.59% | 9.09% |
| Shri Venkatesh Refineries Ltd. | ₹841 Cr | 22.01 | 7.13 | 29.06% | 2.49% |
| KN Agri Resources Limited | ₹537 Cr | 42.66 | 1.4 | 8.23% | 1.75% |
| Modi Naturals Limited | ₹534 Cr | 26.73 | 3.1 | 29.21% | 6.99% |
| Kriti Nutrients Limited | ₹383 Cr | 60.24 | 1.67 | 14.8% | 3.68% |
| M.K.Proteins Limited(this company) | — | 140.67 | 2.08 | — | — |
AI analysis
AI-generated · google/gemini-2.5-flashM.K.Proteins Limited has a market capitalization of Rs 161 Cr. The company's EPS is 0.18 and it has a book value of Rs 2.03. Revenue for the last fiscal year was Rs 268.18 Cr. The promoter holding stands at 74.825%, with the public holding 25.175%.
Positives
- +Promoter holding of 74.825% indicates a significant interest from the founders in the company.
- +The debt-to-equity ratio is 0.45, which indicates a manageable level of debt.
- +Promoter pledge is 0%, indicating no shares held by promoters are pledged.
Negatives
- −Revenue decreased from Rs 246.017681604 Cr in Mar 2024 to Rs 268.18 Cr in Mar 2025, when comparing last two provided annual figures.
- −Net profit saw a decline from Rs 11.211928928 Cr in Mar 2024 to Rs 8.397422277 Cr in Mar 2025.
- −EPS decreased from 0.3 in Mar 2024 to 0.22 in Mar 2025.
- −No quarterly results have been disclosed for periods after Mar 2026, which makes recent performance assessment difficult.
Financial performance
M.K.Proteins Limited reported revenue of Rs 268.18 Cr in the fiscal year ending March 2025. This marks a decrease from Rs 246.017681604 Cr in March 2024. Net profit for March 2025 was Rs 8.397422277 Cr, compared to Rs 11.211928928 Cr in the previous fiscal year. The company's highest annual revenue in the last five years was Rs 315.413494157 Cr in March 2023.
Profitability & returns
The company's profit margin was 178.4%. Return on Equity (ROE) stood at 8.95%, while Return on Capital Employed (ROCE) was 9.909%. The Earnings Per Share (EPS) for March 2025 was 0.22, a decrease from 0.3 in March 2024 and 0.29 in March 2023.
Balance sheet
The debt-to-equity ratio for M.K.Proteins Limited is 0.45. The book value per share is Rs 2.03. No dividends were paid, resulting in a dividend yield of 0%.
Ownership & pledges
Public shareholding is 25.175%. There are no shares pledged by the promoters, with promoter pledge at 0%. The number of shareholders is 70,737 as of June 30, 2026.
Regulatory & surveillance
No information regarding surveillance measures for M.K.Proteins Limited has been provided in the data.
Data as of — price: 2026-07-29 · financials: Mar 25 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.